Distinct host cell proteins incorporated by SIV replicating in CD4+ T Cells from natural disease resistant versus non-natural disease susceptible hosts

Retrovirology

Volumn 7, Issue , 2010, Pages

  Stephenson, Susan T ^a   Bostik, Pavel ^b   Song, Byeongwoon ^a   Rajan, Devi ^a   Bhimani, Samrath ^a   Rehulka, Pavel ^b   Mayne, Ann E ^a   Ansari, Aftab A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; CD3 ANTIGEN; CELL PROTEIN; INTERLEUKIN 13; PROTEINASE; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; INFECTION SENSITIVITY; LENTIVIRUS INFECTION; MACACA; NONHUMAN; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEOMICS; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS ACTIVATION; VIRUS CELL INTERACTION; VIRUS REPLICATION; ANIMAL; CELL CULTURE; CERCOCEBUS; DISEASE PREDISPOSITION; GENETICS; HOST RANGE; IMMUNOLOGY; INNATE IMMUNITY; MACACA MULATTA; METABOLISM; PHYSIOLOGY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA MULATTA; PRIMATES; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CERCOCEBUS ATYS; DISEASE SUSCEPTIBILITY; HOST SPECIFICITY; IMMUNITY, INNATE; MACACA MULATTA; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION;

EID: 78650134469     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-7-107     Document Type: Article

References (78)

1. Ansari AA, Onlamoon N, Bostik P, Mayne AE, Gargano L, Pattanapanyasat K. Lessons learnt from studies of the immune characterization of naturally SIV infected sooty mangabeys. Front Biosci 2003, 8:s1030-1050. 10.2741/1180, 12957849.
2. Sodora DL, Allan JS, Apetrei C, Brenchley JM, Douek DC, Else JG, Estes JD, Hahn BH, Hirsch VM, Kaur A, Kirchhoff F, Muller-Trutwin M, Pandrea I, Schmitz JE, Silvestri G. Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts. Nat Med 2009, 15:861-865. 10.1038/nm.2013, 2782707, 19661993.
3. VandeWoude S, Apetrei C. Going wild: lessons from naturally occurring T-lymphotropic lentiviruses. Clin Microbiol Rev 2006, 19:728-762. 10.1128/CMR.00009-06, 1592692, 17041142.
4. McClure HM, Anderson DC, Fultz PN, Ansari AA, Lockwood E, Brodie A. Spectrum of disease in macaque monkeys chronically infected with SIV/SMM. Vet Immunol Immunopathol 1989, 21:13-24. 10.1016/0165-2427(89)90126-8, 2570479.
5. Cantin R, Methot S, Tremblay MJ. Plunder and stowaways: incorporation of cellular proteins by enveloped viruses. J Virol 2005, 79:6577-6587. 10.1128/JVI.79.11.6577-6587.2005, 1112128, 15890896.
6. Tremblay MJ, Fortin JF, Cantin R. The acquisition of host-encoded proteins by nascent HIV-1. Immunol Today 1998, 19:346-351. 10.1016/S0167-5699(98)01286-9, 9709501.
7. Ott DE. Cellular proteins in HIV virions. Rev Med Virol 1997, 7:167-180. 10.1002/(SICI)1099-1654(199709)7:3<167::AID-RMV199>3.0.CO;2-K, 10398481.
8. Ott DE. Potential roles of cellular proteins in HIV-1. Rev Med Virol 2002, 12:359-374. 10.1002/rmv.367, 12410528.
9. Cantin R, Fortin JF, Lamontagne G, Tremblay M. The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity. J Virol 1997, 71:1922-1930. 191270, 9032323.
10. Fortin JF, Barbeau B, Hedman H, Lundgren E, Tremblay MJ. Role of the leukocyte function antigen-1 conformational state in the process of human immunodeficiency virus type 1-mediated syncytium formation and virus infection. Virology 1999, 257:228-238. 10.1006/viro.1999.9687, 10208936.
11. Fortin JF, Cantin R, Tremblay MJ. T cells expressing activated LFA-1 are more susceptible to infection with human immunodeficiency virus type 1 particles bearing host-encoded ICAM-1. J Virol 1998, 72:2105-2112. 109505, 9499066.
12. Giguere JF, Paquette JS, Bounou S, Cantin R, Tremblay MJ. New insights into the functionality of a virion-anchored host cell membrane protein: CD28 versus HIV type 1. J Immunol 2002, 169:2762-2771.
13. Martin G, Tremblay MJ. HLA-DR, ICAM-1, CD40, CD40L, and CD86 are incorporated to a similar degree into clinical human immunodeficiency virus type 1 variants expanded in natural reservoirs such as peripheral blood mononuclear cells and human lymphoid tissue cultured ex vivo. Clin Immunol 2004, 111:275-285. 10.1016/j.clim.2004.02.004, 15183148.
14. Guo MM, Hildreth JE. HIV acquires functional adhesion receptors from host cells. AIDS Res Hum Retroviruses 1995, 11:1007-1013. 10.1089/aid.1995.11.1007, 8554897.
15. Orentas RJ, Hildreth JE. Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV. AIDS Res Hum Retroviruses 1993, 9:1157-1165. 10.1089/aid.1993.9.1157, 8312057.
16. Bounou S, Dumais N, Tremblay MJ. Attachment of human immunodeficiency virus-1 (HIV-1) particles bearing host-encoded B7-2 proteins leads to nuclear factor-kappa B- and nuclear factor of activated T cells-dependent activation of HIV-1 long terminal repeat transcription. J Biol Chem 2001, 276:6359-6369. 10.1074/jbc.M002198200, 11096063.
17. Esser MT, Graham DR, Coren LV, Trubey CM, Bess JW, Arthur LO, Ott DE, Lifson JD. Differential incorporation of CD45, CD80 (B7-1), CD86 (B7-2), and major histocompatibility complex class I and II molecules into human immunodeficiency virus type 1 virions and microvesicles: implications for viral pathogenesis and immune regulation. J Virol 2001, 75:6173-6182. 10.1128/JVI.75.13.6173-6182.2001, 114333, 11390619.
18. Piatak M, Saag MS, Yang LC, Clark SJ, Kappes JC, Luk KC, Hahn BH, Shaw GM, Lifson JD. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993, 259:1749-1754. 10.1126/science.8096089, 8096089.
19. Chertova E, Chertov O, Coren LV, Roser JD, Trubey CM, Bess JW, Sowder RC, Barsov E, Hood BL, Fisher RJ, Nagashima K, Conrads TP, Veenstra TD, Lifson JD, Ott DE. Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J Virol 2006, 80:9039-9052. 10.1128/JVI.01013-06, 1563931, 16940516.
20. Gladnikoff M, Shimoni E, Gov NS, Rousso I. Retroviral assembly and budding occur through an actin-driven mechanism. Biophys J 2009, 97:2419-2428. 10.1016/j.bpj.2009.08.016, 2770610, 19883584.
21. Morita E, Sundquist WI. Retrovirus budding. Annu Rev Cell Dev Biol 2004, 20:395-425. 10.1146/annurev.cellbio.20.010403.102350, 15473846.
22. Nguyen DH, Hildreth JE. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J Virol 2000, 74:3264-3272. 10.1128/JVI.74.7.3264-3272.2000, 111827, 10708443.
23. Trubey CM, Chertova E, Coren LV, Hilburn JM, Hixson CV, Nagashima K, Lifson JD, Ott DE. Quantitation of HLA class II protein incorporated into human immunodeficiency type 1 virions purified by anti-CD45 immunoaffinity depletion of microvesicles. J Virol 2003, 77:12699-12709. 10.1128/JVI.77.23.12699-12709.2003, 262561, 14610192.
24. Ott DE, Coren LV, Johnson DG, Kane BP, Sowder RC, Kim YD, Fisher RJ, Zhou XZ, Lu KP, Henderson LE. Actin-binding cellular proteins inside human immunodeficiency virus type 1. Virology 2000, 266:42-51. 10.1006/viro.1999.0075, 10612659.
25. Saphire AC, Gallay PA, Bark SJ. Proteomic analysis of human immunodeficiency virus using liquid chromatography/tandem mass spectrometry effectively distinguishes specific incorporated host proteins. J Proteome Res 2006, 5:530-538. 10.1021/pr050276b, 16512667.
26. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, Xavier RJ, Lieberman J, Elledge SJ. Identification of host proteins required for HIV infection through a functional genomic screen. Science 2008, 319:921-926. 10.1126/science.1152725, 18187620.
27. Konig R, Zhou Y, Elleder D, Diamond TL, Bonamy GM, Irelan JT, Chiang CY, Tu BP, De Jesus PD, Lilley CE, Seidel S, Opaluch AM, Caldwell JS, Weitzman MD, Kuhen KL, Bandyopadhyay S, Ideker T, Orth AP, Miraglia LJ, Bushman FD, Young JA, Chanda SK. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 2008, 135:49-60. 10.1016/j.cell.2008.07.032, 2628946, 18854154.
28. Zhou H, Xu M, Huang Q, Gates AT, Zhang XD, Castle JC, Stec E, Ferrer M, Strulovici B, Hazuda DJ, Espeseth AS. Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe 2008, 4:495-504. 10.1016/j.chom.2008.10.004, 18976975.
29. Yeung ML, Houzet L, Yedavalli VS, Jeang KT. A genome-wide short hairpin RNA screening of jurkat T-cells for human proteins contributing to productive HIV-1 replication. J Biol Chem 2009, 284:19463-19473. 10.1074/jbc.M109.010033, 2740572, 19460752.
30. Gautier VW, Gu L, O'Donoghue N, Pennington S, Sheehy N, Hall WW. In vitro nuclear interactome of the HIV-1 Tat protein. Retrovirology 2009, 6:47. 10.1186/1742-4690-6-47, 2702331, 19454010.
31. Pinney JW, Dickerson JE, Fu W, Sanders-Beer BE, Ptak RG, Robertson DL. HIV-host interactions: a map of viral perturbation of the host system. AIDS 2009, 23:549-554.
32. Pickart CM, Cohen RE. Proteasomes and their kin: proteases in the machine age. Nat Rev Mol Cell Biol 2004, 5:177-187. 10.1038/nrm1336, 14990998.
33. Shibuya H, Irie K, Ninomiya-Tsuji J, Goebl M, Taniguchi T, Matsumoto K. New human gene encoding a positive modulator of HIV Tat-mediated transactivation. Nature 1992, 357:700-702. 10.1038/357700a0, 1377363.
34. Makino Y, Yogosawa S, Kayukawa K, Coin F, Egly JM, Wang Z, Roeder RG, Yamamoto K, Muramatsu M, Tamura T. TATA-Binding protein-interacting protein 120, TIP120, stimulates three classes of eukaryotic transcription via a unique mechanism. Mol Cell Biol 1999, 19:7951-7960. 84880, 10567521.
35. Yanagi S, Shimbara N, Tamura T. Tissue and cell distribution of a mammalian proteasomal ATPase, MSS1, and its complex formation with the basal transcription factors. Biochem Biophys Res Commun 2000, 279:568-573. 10.1006/bbrc.2000.3969, 11118327.
36. Bhat KP, Turner JD, Myers SE, Cape AD, Ting JP, Greer SF. The 19 S proteasome ATPase Sug1 plays a critical role in regulating MHC class II transcription. Mol Immunol 2008, 45:2214-2224. 10.1016/j.molimm.2007.12.001, 18215421.
37. Ferdous A, Gonzalez F, Sun L, Kodadek T, Johnston SA. The 19 S regulatory particle of the proteasome is required for efficient transcription elongation by RNA polymerase II. Mol Cell 2001, 7:981-991. 10.1016/S1097-2765(01)00250-7, 11389845.
38. Ferdous A, Kodadek T, Johnston SA. A nonproteolytic function of the 19 S regulatory subunit of the 26 S proteasome is required for efficient activated transcription by human RNA polymerase II. Biochemistry 2002, 41:12798-12805. 10.1021/bi020425t, 12379122.
39. Gonzalez F, Delahodde A, Kodadek T, Johnston SA. Recruitment of a 19 S proteasome subcomplex to an activated promoter. Science 2002, 296:548-550. 10.1126/science.1069490, 11964484.
40. Lassot I, Latreille D, Rousset E, Sourisseau M, Linares LK, Chable-Bessia C, Coux O, Benkirane M, Kiernan RE. The proteasome regulates HIV-1 transcription by both proteolytic and nonproteolytic mechanisms. Mol Cell 2007, 25:369-383. 10.1016/j.molcel.2006.12.020, 17289585.
41. Wang Y, Li Y, Qi X, Yuan W, Ai J, Zhu C, Cao L, Yang H, Liu F, Wu X, Liu M. TRIM45, a novel human RBCC/TRIM protein, inhibits transcriptional activities of ElK-1 and AP-1. Biochem Biophys Res Commun 2004, 323:9-16. 10.1016/j.bbrc.2004.08.048, 15351693.
42. Dave VP. Hierarchical role of CD3 chains in thymocyte development. Immunol Rev 2009, 232:22-33. 10.1111/j.1600-065X.2009.00835.x, 19909353.
43. Wu JQ, Wang B, Belov L, Chrisp J, Learmont J, Dyer WB, Zaunders J, Cunningham AL, Dwyer DE, Saksena NK. Antibody microarray analysis of cell surface antigens on CD4+ and CD8+ T cells from HIV+ individuals correlates with disease stages. Retrovirology 2007, 4:83. 10.1186/1742-4690-4-83, 2212635, 18036256.
44. Gorman CL, Monaco C, Ammiratti E, Vermi AC, Marelli-Berg FM, Cope AP. Tracking antigen-experienced effector T cells in vitro and in vivo. Methods Mol Biol 2010, 616:253-267. full_text, 20379880.
45. Croft M. Control of immunity by the TNFR-related molecule OX40 (CD134). Annu Rev Immunol 2010, 28:57-78. 10.1146/annurev-immunol-030409-101243, 20307208.
46. Kaizuka Y, Douglass AD, Vardhana S, Dustin ML, Vale RD. The coreceptor CD2 uses plasma membrane microdomains to transduce signals in T cells. J Cell Biol 2009, 185:521-534. 10.1083/jcb.200809136, 2700390, 19398758.
47. Umehara H, Huang JY, Kono T, Tabassam FH, Okazaki T, Gouda S, Nagano Y, Bloom ET, Domae N. Co-stimulation of T cells with CD2 augments TCR-CD3-mediated activation of protein tyrosine kinase p72syk, resulting in increased tyrosine phosphorylation of adapter proteins, Shc and Cbl. Int Immunol 1998, 10:833-845. 10.1093/intimm/10.6.833, 9678765.
48. Masuda K, Davis RS, Maruyama T, Zhang J, He T, Cooper MD, J OW, Burrows PD. FcRY, an Fc receptor related gene differentially expressed during B lymphocyte development and activation. Gene 2005, 363:32-40. 10.1016/j.gene.2005.08.016, 16263223.
49. Hamidouche Z, Fromigue O, Ringe J, Haupl T, Marie PJ. Crosstalks between integrin alpha 5 and IGF2/IGFBP2 signalling trigger human bone marrow-derived mesenchymal stromal osteogenic differentiation. BMC Cell Biol 2010, 11:44. 10.1186/1471-2121-11-44, 2901205, 20573191.
50. Brightling CE, Saha S, Hollins F. Interleukin-13: prospects for new treatments. Clin Exp Allergy 2010, 40:42-49.
51. Hopkin J. Immune and genetic aspects of asthma, allergy and parasitic worm infections: evolutionary links. Parasite Immunol 2009, 31:267-273. 10.1111/j.1365-3024.2009.01104.x, 19388947.
52. Mandal D, Fu P, Levine AD. REDOX regulation of IL-13 signaling in intestinal epithelial cells: usage of alternate pathways mediates distinct gene expression patterns. Cell Signal 2010, 22:1485-1494. 10.1016/j.cellsig.2010.05.017, 20570727.
53. Heller F, Florian P, Bojarski C, Richter J, Christ M, Hillenbrand B, Mankertz J, Gitter AH, Burgel N, Fromm M, Zeitz M, Fuss I, Strober W, Schulzke JD. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 2005, 129:550-564.
54. Nazli A, Chan O, Dobson-Belaire WN, Ouellet M, Tremblay MJ, Gray-Owen SD, Arsenault AL, Kaushic C. Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS Pathog 2010, 6:e1000852. 10.1371/journal.ppat.1000852, 2851733, 20386714.
55. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D, Blazar BR, Rodriguez B, Teixeira-Johnson L, Landay A, Martin JN, Hecht FM, Picker LJ, Lederman MM, Deeks SG, Douek DC. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006, 12:1365-1371. 10.1038/nm1511, 17115046.
56. Chen LW, Chang WJ, Chen PH, Hsu CM. Commensal microflora induce host defense and decrease bacterial translocation in burn mice through toll-like receptor 4. J Biomed Sci 2010, 17:48. 10.1186/1423-0127-17-48, 2901327, 20540783.
57. Brenchley JM, Silvestri G, Douek DC. Nonprogressive and progressive primate immunodeficiency lentivirus infections. Immunity 2010, 32:737-742. 10.1016/j.immuni.2010.06.004, 20620940.
58. Lepelletier Y, Zollinger R, Ghirelli C, Raynaud F, Hadj-Slimane R, Cappuccio A, Hermine O, Liu YJ, Soumelis V. Toll-like receptor control of glucocorticoid-induced apoptosis in human plasmacytoid pre-dendritic cells (pDC). Blood 2010,
59. Morel C, Adami P, Musard JF, Duval D, Radom J, Jouvenot M. Involvement of sulfhydryl oxidase QSOX1 in the protection of cells against oxidative stress-induced apoptosis. Exp Cell Res 2007, 313:3971-3982. 10.1016/j.yexcr.2007.09.003, 17927979.
60. Ding Y, Lu B, Chen D, Meng L, Shen Y, Chen S. Proteomic analysis of colonic mucosa in a rat model of irritable bowel syndrome. Proteomics 2010,
61. Kienzl K, Sarg B, Golderer G, Obrist P, Werner ER, Werner-Felmayer G, Lindner H, Maglione M, Schneeberger S, Margreiter R, Brandacher G. Proteomic profiling of acute cardiac allograft rejection. Transplantation 2009, 88:553-560. 10.1097/TP.0b013e3181b119b1, 19696639.
62. Zhang J, Kang B, Tan X, Bai Z, Liang Y, Xing R, Shao J, Xu N, Wang R, Liu S, Lu Y. Comparative analysis of the protein profiles from primary gastric tumors and their adjacent regions: MAWBP could be a new protein candidate involved in gastric cancer. J Proteome Res 2007, 6:4423-4432. 10.1021/pr0703425, 17929853.
63. Datta PK, Moses HL. STRAP and Smad7 synergize in the inhibition of transforming growth factor beta signaling. Mol Cell Biol 2000, 20:3157-3167. 10.1128/MCB.20.9.3157-3167.2000, 85610, 10757800.
64. Tollervey D. Molecular biology: RNA lost in translation. Nature 2006, 440:425-426. 10.1038/440425a, 16554791.
65. Booth AM, Fang Y, Fallon JK, Yang JM, Hildreth JE, Gould SJ. Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane. J Cell Biol 2006, 172:923-935. 10.1083/jcb.200508014, 2063735, 16533950.
66. Izquierdo-Useros N, Naranjo-Gomez M, Archer J, Hatch SC, Erkizia I, Blanco J, Borras FE, Puertas MC, Connor JH, Fernandez-Figueras MT, et al. Capture and transfer of HIV-1 particles by mature dendritic cells converges with the exosome-dissemination pathway. Blood 2009, 113:2732-2741. 10.1182/blood-2008-05-158642, 2661860, 18945959.
67. van Dijk D, Ertaylan G, Boucher CA, Sloot PM. Identifying potential survival strategies of HIV-1 through virus-host protein interaction networks. BMC Syst Biol 2010, 4:96. 10.1186/1752-0509-4-96, 2913931, 20633292.
68. Kolegraff K, Bostik P, Ansari AA. Characterization and role of lentivirus-associated host proteins. Exp Biol Med (Maywood) 2006, 231:252-263.
69. Raghavendra NK, Shkriabai N, Graham R, Hess S, Kvaratskhelia M, Wu L. Identification of host proteins associated with HIV-1 preintegration complexes isolated from infected CD4+ cells. Retrovirology 2010, 7:66. 10.1186/1742-4690-7-66, 2924840, 20698996.
70. Esser MT, Bess JW, Suryanarayana K, Chertova E, Marti D, Carrington M, Arthur LO, Lifson JD. Partial activation and induction of apoptosis in CD4(+) and CD8(+) T lymphocytes by conformationally authentic noninfectious human immunodeficiency virus type 1. J Virol 2001, 75:1152-1164. 10.1128/JVI.75.3.1152-1164.2001, 114021, 11152488.
71. Bostik P, Mayne AE, Villinger F, Greenberg KP, Powell JD, Ansari AA. Relative resistance in the development of T cell anergy in CD4+ T cells from simian immunodeficiency virus disease-resistant sooty mangabeys. J Immunol 2001, 166:506-516.
72. Pandrea I, Apetrei C, Gordon S, Barbercheck J, Dufour J, Bohm R, Sumpter B, Roques P, Marx PA, Hirsch VM, Kaur A, Lackner AA, Veazey RS, Silvestri G. Paucity of CD4+CCR5+ T cells is a typical feature of natural SIV hosts. Blood 2007, 109:1069-1076. 10.1182/blood-2006-05-024364, 1785133, 17003371.
73. Roy J, Martin G, Giguere JF, Belanger D, Petrin M, Tremblay MJ. HIV type 1 can act as an APC upon acquisition from the host cell of peptide-loaded HLA-DR and CD86 molecules. J Immunol 2005, 174:4779-4788.
74. Dubiel W, Ferrell K, Rechsteiner M. Peptide sequencing identifies MSS1, a modulator of HIV Tat-mediated transactivation, as subunit 7 of the 26 S protease. FEBS Lett 1993, 323:276-278. 10.1016/0014-5793(93)81356-5, 8500623.
75. Mori K, Yasutomi Y, Sawada S, Villinger F, Sugama K, Rosenwith B, Heeney JL, Uberla K, Yamazaki S, Ansari AA, Rubsamen-Waigmann H. Suppression of acute viremia by short-term postexposure prophylaxis of simian/human immunodeficiency virus SHIV-RT-infected monkeys with a novel reverse transcriptase inhibitor (GW420867) allows for development of potent antiviral immune responses resulting in efficient containment of infection. J Virol 2000, 74:5747-5753. 10.1128/JVI.74.13.5747-5753.2000, 112067, 10846052.
76. Villinger F, Brice GT, Mayne AE, Bostik P, Mori K, June CH, Ansari AA. Adoptive transfer of simian immunodeficiency virus (SIV) naive autologous CD4(+) cells to macaques chronically infected with SIV is sufficient to induce long-term nonprogressor status. Blood 2002, 99:590-599. 10.1182/blood.V99.2.590, 11781243.
77. Peng J, Gygi SP. Proteomics: the move to mixtures. J Mass Spectrom 2001, 36:1083-1091. 10.1002/jms.229, 11747101.
78. Peng J, Elias JE, Thoreen CC, Licklider LJ, Gygi SP. Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale protein analysis: the yeast proteome. J Proteome Res 2003, 2:43-50. 10.1021/pr025556v, 12643542.